BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2972939)

  • 1. Beta-endorphin-(1-27) antagonizes beta-endorphin- but not morphine-, D-Pen2-D-Pen5-enkephalin- and U50, 488H-induced analgesia in mice.
    Suh HH; Tseng LF; Li CH
    Neuropharmacology; 1988 Sep; 27(9):957-63. PubMed ID: 2972939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different types of opioid receptors mediating analgesia induced by morphine, DAMGO, DPDPE, DADLE and beta-endorphin in mice.
    Suh HH; Tseng LF
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Jul; 342(1):67-71. PubMed ID: 1976234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse.
    Porreca F; Mosberg HI; Hurst R; Hruby VJ; Burks TF
    J Pharmacol Exp Ther; 1984 Aug; 230(2):341-8. PubMed ID: 6086883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delta but not mu-opioid receptors in the spinal cord are involved in antinociception induced by beta-endorphin given intracerebroventricularly in mice.
    Suh HH; Tseng LF
    J Pharmacol Exp Ther; 1990 Jun; 253(3):981-6. PubMed ID: 2162954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antinociceptive profiles of opioid peptide agonists in a rat tooth pulp stimulation procedure.
    Steinfels GF; Cook L
    Peptides; 1985; 6 Suppl 2():171-5. PubMed ID: 2867529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiplicative interaction between intrathecally and intracerebroventricularly administered mu opioid agonists but limited interactions between delta and kappa agonists for antinociception in mice.
    Roerig SC; Fujimoto JM
    J Pharmacol Exp Ther; 1989 Jun; 249(3):762-8. PubMed ID: 2567350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of mu and delta receptors in the supraspinal and spinal analgesic effects of [D-Pen2, D-Pen5]enkephalin in the mouse.
    Porreca F; Heyman JS; Mosberg HI; Omnaas JR; Vaught JL
    J Pharmacol Exp Ther; 1987 May; 241(2):393-400. PubMed ID: 3033214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antinociception produced by intrathecal morphine, calcium, A23187, U50,488H, [D-Ala2, N-Me-Phe4, Gly-ol]enkephalin and [D-Pen2, D-Pen5]enkephalin after intrathecal administration of calcitonin gene-related peptide in mice.
    Welch SP; Singha AK; Dewey WL
    J Pharmacol Exp Ther; 1989 Oct; 251(1):1-8. PubMed ID: 2552070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of central and peripheral mu, delta and kappa opioid receptors in the mediation of gastric acid secretory effects in the rat.
    Fox DA; Burks TF
    J Pharmacol Exp Ther; 1988 Feb; 244(2):456-62. PubMed ID: 2831341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholecystokinin administered intrathecally selectively antagonizes intracerebroventricular beta-endorphin-induced tail-flick inhibition in the mouse.
    Tseng LF; Collins KA
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1086-92. PubMed ID: 1545380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. U50,488H differentially antagonizes the bladder effects of mu agonists at spinal sites.
    Sheldon RJ; Nunan L; Porreca F
    Eur J Pharmacol; 1988 Feb; 146(2-3):229-35. PubMed ID: 2836207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by mu-opioid agonists, but not by delta- and kappa-opioid agonists.
    Kamei J; Ohhashi Y; Aoki T; Kawasima N; Kasuya Y
    Brain Res; 1992 Feb; 571(2):199-203. PubMed ID: 1319265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of delta receptor mediation of supraspinal opioid analgesia by in vivo protection against the beta-funaltrexamine antagonist effect.
    Sánchez-Blázquez P; Garzón J
    Eur J Pharmacol; 1989 Jan; 159(1):9-23. PubMed ID: 2565240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolerance to delta- but not mu-opioid receptors in the spinal cord attenuates inhibition of the tail-flick response induced by beta-endorphin administered intracerebroventricularly in mice.
    Suh HH; Tseng LF
    Pharmacol Biochem Behav; 1990 Apr; 35(4):807-13. PubMed ID: 2161107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of opioid receptors modulating the function of capsaicin-sensitive neurons in guinea-pig atria.
    Mantelli L; Amerini S; Rubino A; Ledda F
    Eur J Pharmacol; 1990 May; 180(2-3):325-30. PubMed ID: 1973118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracerebroventricular N-ethylmaleimide differentially reduces supraspinal opioid analgesia in mice.
    Sánchez-Blázquez P; Ulibarri I; Garzón J
    Eur J Pharmacol; 1989 Jul; 166(2):193-200. PubMed ID: 2676563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid modulation of basal intestinal fluid transport in the mouse: actions at central, but not intestinal, sites.
    Jiang Q; Sheldon RJ; Porreca F
    J Pharmacol Exp Ther; 1990 May; 253(2):784-90. PubMed ID: 2160010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mu antagonist properties of kappa agonists in a model of rat urinary bladder motility in vivo.
    Sheldon RJ; Nunan L; Porreca F
    J Pharmacol Exp Ther; 1987 Oct; 243(1):234-40. PubMed ID: 2822899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antidiarrheal properties of supraspinal mu and delta and peripheral mu, delta and kappa opioid receptors: inhibition of diarrhea without constipation.
    Shook JE; Lemcke PK; Gehrig CA; Hruby VJ; Burks TF
    J Pharmacol Exp Ther; 1989 Apr; 249(1):83-90. PubMed ID: 2540324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further characterization of alpha N-acetyl beta-endorphin-(1-31) regulatory activity, I: Effect on opioid- and alpha 2-mediated supraspinal antinociception in mice.
    Sánchez-Blázquez P; Garzón J
    Life Sci; 1992; 50(26):2083-97. PubMed ID: 1318989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.